BRUFX
Price
$641.31
Change
-$2.50 (-0.39%)
Updated
Aug 21 closing price
Net Assets
383.43M
FFIFX
Price
$28.53
Change
+$0.14 (+0.49%)
Updated
Aug 21 closing price
Net Assets
148.23B
Interact to see
Advertisement

BRUFX vs FFIFX

BRUFX vs FFIFX Comparison Chart in %
View a ticker or compare two or three
VS
BRUFX vs. FFIFX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRUFX is a Hold and FFIFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FFIFX has more cash in the bank: 148B vs. BRUFX (383M). FFIFX pays higher dividends than BRUFX: FFIFX (3.65) vs BRUFX (2.19). BRUFX was incepted earlier than FFIFX: BRUFX (58 years) vs FFIFX (6 years). BRUFX (0.64) is less costly to investors than FFIFX (0.31). FFIFX is a more actively managed with annual turnover of: 65.00 vs. BRUFX (11.00). FFIFX has a lower initial minimum investment than BRUFX: FFIFX (250) vs BRUFX (1000). BRUFX annual gain was more profitable for investors over the last year : 22.19 vs. FFIFX (9.64). FFIFX return over 5 years is better than : 32.56 vs. BRUFX (1.92).
BRUFXFFIFXBRUFX / FFIFX
Total Expense Ratio0.640.31206%
Annual Report Gross Expense Ratio0.640.31206%
Fund Existence58 years6 years-
Gain YTD18.88210.776175%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets383M148B0%
Annual Yield % from dividends2.193.6560%
Returns for 1 year22.199.64230%
Returns for 3 years37.0643.5585%
Returns for 5 years1.9232.566%
Returns for 10 years49.66N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFARX38.080.28
+0.74%
JHancock Fundamental All Cap Core R4
TLVIX38.450.27
+0.71%
Thrivent Large Cap Value S
MXISX15.840.11
+0.70%
Empower S&P SmallCap 600® Index Inv
CSDGX17.190.08
+0.47%
Copeland SMID Cap Dividend Growth A
FOTGX29.64N/A
N/A
Fidelity Advisor OTC C